Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients(†)

OBJECTIVE: Panitumumab was approved in Japan in April 2010 for the treatment of Kirsten rat sarcoma-2 virus oncogene wild-type unresectable and recurrent colorectal cancer. We conducted a post-marketing surveillance study to evaluate the safety and effectiveness of panitumumab. METHODS: After panitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boku, Narikazu, Sugihara, Kenichi, Kitagawa, Yuko, Hatake, Kiyohiko, Gemma, Akihiko, Yamazaki, Naoya, Muro, Kei, Hamaguchi, Tetsuya, Yoshino, Takayuki, Yana, Ikuo, Ueno, Hiroshi, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941645/
https://www.ncbi.nlm.nih.gov/pubmed/24526771
http://dx.doi.org/10.1093/jjco/hyt196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941645/
https://www.ncbi.nlm.nih.gov/pubmed/24526771
http://dx.doi.org/10.1093/jjco/hyt196

Ejemplares similares